Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Net Margin (2020 - 2025)

Historic Net Margin for Bioventus (BVS) over the last 5 years, with Q3 2025 value amounting to 2.89%.

  • Bioventus' Net Margin changed N/A to 2.89% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.77%, marking a year-over-year change of. This contributed to the annual value of 14.53% for FY2023, which is 11000.0% down from last year.
  • Latest data reveals that Bioventus reported Net Margin of 2.89% as of Q3 2025.
  • Bioventus' Net Margin's 5-year high stood at 29.99% during Q2 2021, with a 5-year trough of 62.51% in Q2 2023.
  • In the last 4 years, Bioventus' Net Margin had a median value of 1.21% in 2021 and averaged 7.65%.
  • In the last 5 years, Bioventus' Net Margin soared by 166600bps in 2021 and then plummeted by -621700bps in 2023.
  • Quarter analysis of 4 years shows Bioventus' Net Margin stood at 0.02% in 2021, then plummeted by -96890bps to 18.59% in 2022, then tumbled by -236bps to 62.51% in 2023, then soared by 105bps to 2.89% in 2025.
  • Its Net Margin stands at 2.89% for Q3 2025, versus 6.28% for Q2 2025 and 2.68% for Q1 2025.